Literature DB >> 21950763

Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation.

Stavros Dimopoulos1, Nikolaos Diakos, Eleni Tseliou, Athanasios Tasoulis, Anthi Mpouchla, Christos Manetos, Lambros Katsaros, Stavros Drakos, John Terrovitis, Serafim Nanas.   

Abstract

BACKGROUND: Chronotropic response to exercise and heart rate recovery immediately after exercise (HRR(1) ) are valid prognostic markers in patients with chronic heart failure (CHF). The aim of this study was to evaluate heart rate profile during and after exercise in CHF patients early after left ventricular assist device (LVAD) implantation.
METHODS: We enrolled seven stable consecutive CHF patients (five males, mean age: 45 ± 16 years) after 1 month of LVAD (HeartMate II; Thoratec Corp, Pleasanton, CA, USA) implantation, seven healthy subjects, and 14 patients with advanced HF (HF control group) who performed an incremental symptom-limited cardiopulmonary exercise testing (CPET). CHF patients performed CPET at 1 and 3 months after LVAD. HRR(1) was defined as the HR difference from peak to 1 minute after exercise and chronotropic response to exercise as the chronotropic reserve ([CR, %]=[peak HR-resting HR/220-age-resting HR]× 100).
RESULTS: LVAD patients 3 months after implantation had a significantly different HR profile during exercise compared to healthy controls, with significantly lower CR (57 ± 31 vs 90 ± 14, %, P < 0.001) and HRR(1) (14 ± 6 vs 28 ± 8, bpm, P < 0.01). HR profile during exercise did not significantly change 1 and 3 months after LVAD implantation. There was no statistical difference compared to HF control group and LVAD group regarding cardiopulmonary parameters.
CONCLUSIONS: LVAD patients present an impaired CR and an abnormal HRR(1) after implantation, indicating significant cardiac autonomic abnormalities. These alterations seem to remain unaltered 3 months after LVAD implantation. ©2011, The Authors. Journal compilation ©2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21950763     DOI: 10.1111/j.1540-8159.2011.03215.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  6 in total

1.  Bridge to recovery: understanding the disconnect between clinical and biological outcomes.

Authors:  Stavros G Drakos; Abdallah G Kfoury; Josef Stehlik; Craig H Selzman; Bruce B Reid; John V Terrovitis; John N Nanas; Dean Y Li
Journal:  Circulation       Date:  2012-07-10       Impact factor: 29.690

Review 2.  [Hemodynamics and physical capacity in patients with left ventricular assist devices : An overview].

Authors:  N Reiss; M Altesellmeier; S Mommertz; T Schmidt; S Schulte-Eistrup; D Willemsen
Journal:  Herz       Date:  2016-02-11       Impact factor: 1.443

Review 3.  Clinical Outcomes, Trends in Weight, and Weight Loss Strategies in Patients With Obesity After Durable Ventricular Assist Device Implantation.

Authors:  Naga Vaishnavi Gadela; Devika Umashanker; Andrew Scatola; Abhishek Jaiswal
Journal:  Curr Heart Fail Rep       Date:  2021-01-09

4.  One year improvement of exercise capacity in patients with mechanical circulatory support as bridge to transplantation.

Authors:  Susanne E A Felix; Martinus I F Oerlemans; Faiz Z Ramjankhan; Steven A Muller; Hans H Kirkels; Linda W van Laake; Willem J L Suyker; Folkert W Asselbergs; Nicolaas de Jonge
Journal:  ESC Heart Fail       Date:  2021-03-12

5.  Survival after left ventricular assist device implantation correlates with a novel device-based measure of heart rate variability: the heart rate score.

Authors:  Thomas Czermak; Valentina Seitelberger; Christian Hagl; Patrick-Nicolas Samson-Himmelstjerna; Sven Groß; Sebastian Sadoni; Oliver Heyn; Antonia Kellnar; Bonnie Hartrampf; Eric Lemmermöhle; Ina Klier; Raphael Rehms; Sabine Hoffmann; Heidi L Estner; Stephanie Fichtner; Korbinian Lackermair
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

6.  Abnormal heart rate recovery in patients with heart failure: an important target for exercise training treatment.

Authors:  Stavros Dimopoulos
Journal:  Anatol J Cardiol       Date:  2015-09       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.